Weikang Bio-Technology Group (fka WKBT)

[pappy]

Operating cashflow is growing rapidly while the pps is shrinking even faster[although of late it has steadied around $0.30+or-a few pennies.

June 30th,2010 WKBT had cashflow of $17.10M & by Dec.31st,2011 ttm cashflow was $30.45M.

This strong cashflow has built total cash to $70.78M or $2.06 per share with B.V. @$3.25.

So cashflow alone will easily finance organic growth leaving the strong & growing cash pile to either be used to finance acquisitions or give investors a dividend.

Cash on hand would easily finance a buyout.

To date WKBT has bought a building for $14M to accomadate future growth.

But even after spending $14M in cash to buy a building cash has continued to grow because ttm cashflow is growing faster than outlays by a wide margin.

The cash has been audited & Independantly verified by a top auditing firm not once but twice so why is the pps around $0.30?

I believe the CEO holds the key to not only the strong corp. growth WKBT has had & should continue to have.

But will he share the wealth with investors?

I think this last question is what concerns prospective investors most since with WKBT's strong pipeline of new products I look for 30%+ growth in revenue & earnings to continue & for 2012 I see $1.15 eps easily attainable.

I will continue to hold my growing sharecount that I last added to @$0.27 until I get some answers as I believe the risk is down to zero if the CEO runs with the cash & the potential reward is 10 to 100 fold from the current pps in say 5 years.